Perform Another (Advanced) Search

1.  News: Rituximab Hits Endpoints for New Indication (Clinical Trials Today)
...News: Rituximab Hits Endpoints for New Indication (Clinical Trials Today) Content-Language: en-us description: Roche issued positive results from a phase III trial of MabThera (Rituxan, rituximab) as a first-line therapy for rheumatoid arthritis. This international, randomized, placebo controlled, double blind ...
View Page

2.  Study Posting (4519) Trial #158154, Rheumatoid Arthritis, Tunis, Tunisia
...Study Posting (4519) Trial #158154, Rheumatoid Arthritis, Tunis, Tunisia Trial Information A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Status: Recruiting ...
...Pharmaceutical Official Scientific Title: An open label study to evaluate the safety and efficacy of Rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment ...
View Page

3.  Study Posting (4519) Trial #158157, Rheumatoid Arthritis, Sousse, Tunisia
...Study Posting (4519) Trial #158157, Rheumatoid Arthritis, Sousse, Tunisia Trial Information A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Status: Recruiting ...
...Pharmaceutical Official Scientific Title: An open label study to evaluate the safety and efficacy of Rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment ...
View Page

4.  Study Posting (4519) Trial #157394, Rheumatoid Arthritis, Salé, Morocco
...Study Posting (4519) Trial #157394, Rheumatoid Arthritis, Salé, Morocco Trial Information A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Status: No ...
...Pharmaceutical Official Scientific Title: An open label study to evaluate the safety and efficacy of rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment ...
View Page

5.  Study Posting (4519) Trial #157275, Rheumatoid Arthritis, Rabat, Morocco
...Study Posting (4519) Trial #157275, Rheumatoid Arthritis, Rabat, Morocco Trial Information A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Status: No ...
...Pharmaceutical Official Scientific Title: An open label study to evaluate the safety and efficacy of rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment ...
View Page

6.  Study Posting (4519) Trial #157363, Rheumatoid Arthritis, Marrakech, Morocco
...Study Posting (4519) Trial #157363, Rheumatoid Arthritis, Marrakech, Morocco Trial Information A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Status: No ...
...Pharmaceutical Official Scientific Title: An open label study to evaluate the safety and efficacy of rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment ...
View Page

7.  Study Posting (4519) Trial #157265, Rheumatoid Arthritis, Casablanca, Morocco
...Study Posting (4519) Trial #157265, Rheumatoid Arthritis, Casablanca, Morocco Trial Information A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Status: No ...
...Pharmaceutical Official Scientific Title: An open label study to evaluate the safety and efficacy of rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment ...
View Page

8.  Study Posting (4519) Trial #127202, Rheumatoid Arthritis, Izmir, Turkey
...4519) Trial #127202, Rheumatoid Arthritis, Izmir, Turkey Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

9.  Study Posting (4519) Trial #127203, Rheumatoid Arthritis, Istanbul, Turkey
...4519) Trial #127203, Rheumatoid Arthritis, Istanbul, Turkey Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

10.  Study Posting (4519) Trial #127204, Rheumatoid Arthritis, Antalya, Turkey
...4519) Trial #127204, Rheumatoid Arthritis, Antalya, Turkey Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

11.  Study Posting (4519) Trial #127195, Rheumatoid Arthritis, Ankara, Turkey
...4519) Trial #127195, Rheumatoid Arthritis, Ankara, Turkey Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

12.  Study Posting (4519) Trial #127193, Rheumatoid Arthritis, Adana, Turkey
...4519) Trial #127193, Rheumatoid Arthritis, Adana, Turkey Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

13.  Study Posting (4519) Trial #127211, Rheumatoid Arthritis, Bern, Switzerland
...4519) Trial #127211, Rheumatoid Arthritis, Bern, Switzerland Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

14.  Study Posting (4519) Trial #127210, Rheumatoid Arthritis, Valencia, Spain
...4519) Trial #127210, Rheumatoid Arthritis, Valencia, Spain Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

15.  Study Posting (4519) Trial #127223, Rheumatoid Arthritis, Sevilla, Spain
...4519) Trial #127223, Rheumatoid Arthritis, Sevilla, Spain Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

16.  Study Posting (4519) Trial #127213, Rheumatoid Arthritis, Malaga, Spain
...4519) Trial #127213, Rheumatoid Arthritis, Malaga, Spain Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

17.  Study Posting (4519) Trial #127233, Rheumatoid Arthritis, Madrid, Spain
...4519) Trial #127233, Rheumatoid Arthritis, Madrid, Spain Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

18.  Study Posting (4519) Trial #127234, Rheumatoid Arthritis, Barcelona, Spain
...4519) Trial #127234, Rheumatoid Arthritis, Barcelona, Spain Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

19.  Study Posting (4519) Trial #127236, Rheumatoid Arthritis, Bucharest, Romania
...4519) Trial #127236, Rheumatoid Arthritis, Bucharest, Romania Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page

20.  Study Posting (4519) Trial #127235, Rheumatoid Arthritis, Oslo, Norway
...4519) Trial #127235, Rheumatoid Arthritis, Oslo, Norway Trial Information SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. Status: No longer recruiting Protocol ...
...Division: Pharmaceutical Official Scientific Title: A randomized, placebo controlled, multicenter clinical study investigating efficacy of rituximab (Mabthera/Rituxan) in the inhibition of joint structural damage assessed by magnetic resonance imaging in ...
View Page